Features Headliner: Dexcom device executive presses connectivity

Headliner: Dexcom device executive presses connectivity

"Some people wake up in the middle of the night worrying about business," Kevin Sayer says. But when he wakes up he can't sleep because he's so excited!

Features Rare Diseases: Target Practice

Rare Diseases: Target Practice

The orphan-drug market was flying high before President Obama announced plans to devote $215 million to the funding of a Precision Medicine Initiative. Imagine the excitement among interested audiences now that those plans have picked up momentum. Frank Celia reports

Features DTC Report: DTC Unbound

DTC Report: DTC Unbound

DTC pharma advertising works—ask anyone. But over the years, its effectiveness has been blunted by FDA requirements that, marketers claim, befog rather than clarify. Larry Dobrow surveys the DTC landscape in the wake of the FDA's new—and some say revolutionary—guidance for communicating risk information in print ads

Features Drew Miller, Creative Director, frog design

Drew Miller, Creative Director, frog design

Session: Shifting Healthcare from Product to Experience

Features MarlaJan DeFusco BSN, RN, CPN, Lupus Health Activist, & Author, Luck Fupus Blog

MarlaJan DeFusco BSN, RN, CPN, Lupus Health Activist, & Author, Luck Fupus Blog

Session: The patient view on transformation: empathy, education and empowerment

Features Monique Levy, Vice President, Research, Manhattan Research

Monique Levy, Vice President, Research, Manhattan Research

Session: Closing Keynote

Features Dr. Navarra Rodriguez, Chief Medical Informatics Officer, AdvantageCare Physicians

Dr. Navarra Rodriguez, Chief Medical Informatics Officer, AdvantageCare Physicians

Session: The patient view on transformation: empathy, education and empowerment

Features DTC Report: Ten Best DTC Ads of 2014

DTC Report: Ten Best DTC Ads of 2014

Below, a review of last year's 10 best DTC ads, excerpted from MM&M's April cover story, "DTC Report: DTC Unbound," which will be viewable online on Wednesday, March 25. Mary Skoyles reports

Features Matt Brown, CEO, Guidemark Health

Matt Brown, CEO, Guidemark Health

Session: Inspiring the Future 40

Features Jack Barrette, CEO, WEGO Health

Jack Barrette, CEO, WEGO Health

Session: What is a business model and how do you sell it?

Features Lita Sands, Former Global Head, Digital Transformation, Novartis

Lita Sands, Former Global Head, Digital Transformation, Novartis

Session: The patient view on transformation: empathy, education and empowerment

Features Tom Kottler, CEO and Co-Founder of HealthPrize Technologies

Tom Kottler, CEO and Co-Founder of HealthPrize Technologies

Session: What is a business model and how do you sell it?

Features Larry Brooks, Director, Business Innovation: Digital Health at Boehringer Ingelheim

Larry Brooks, Director, Business Innovation: Digital Health at Boehringer Ingelheim

Session: What is a business model and how do you sell it?

Features Read the complete MM&M Digital Guide 2015

Read the complete MM&M Digital Guide 2015

Click the link below to access MM&M's Digital Guide 2015, with all text, charts and pictures.

Features Melissa Manice, CoheroHealth, CEO and Co-founder

Melissa Manice, CoheroHealth, CEO and Co-founder

Session: Battle of the Big Idea

Features Andy DiSimone, Director of Digital, StartUp Health

Andy DiSimone, Director of Digital, StartUp Health

Session: Battle of the Big Idea

Features Read the complete March 2015 Digital Edition

Read the complete March 2015 Digital Edition

Click the above link to access the Digital Edition of the March 2015 issue of MM&M, with all text, charts and pictures.

Features Mark Hadfield, CEO & Founder, HelloMD

Mark Hadfield, CEO & Founder, HelloMD

Session: Inter-generational Executive Summit Panel

Features Brandon Seeyle, Marketing Product Manager, Medivation

Brandon Seeyle, Marketing Product Manager, Medivation

Session: Intelligent Connections

Features

Companies at a Glance 2015

Features Digital Partners 2015

Digital Partners 2015

Features

Think Tank: There's Work to Do

Five digital pharma experts benchmark the industry's progress and project the next big digital trends

Features Consumers: Patients and Virtues

Consumers: Patients and Virtues

Consumers come with the same basic set of instructions as HCPs—find out what they need, then offer meaningful solutions. But be warned: Shiny objects may cause a temporary loss of vision

Features Healthcare Professionals: Chaos Breeds Opportunity

Healthcare Professionals: Chaos Breeds Opportunity

Increasingly pressed for time, the last thing physicians need is more engagement opportunities with pharma, right? Wrong. It's all about offering the right content in the right format at the right time

Features Overview: Can't, Won't, Don't Stop

Overview: Can't, Won't, Don't Stop

As pharma continues to scale the digital curve, James Chase's assessment of the landscape paints a familiar picture of progress and encouragement mixed with frustration and pain

Features Joe Shields, Global Director, Digital Strategy, AstraZeneca Pharmaceuticals

Joe Shields, Global Director, Digital Strategy, AstraZeneca Pharmaceuticals

Session: Battle of the Big Idea

Features Skill Sets: Cello Health Insight

Skill Sets: Cello Health Insight

A monthly showcase of companies offering expertise, experience and services within specific areas of the industry. In this edition: multichannel marketing

Features MAHF 2015: An Evening of Icons

MAHF 2015: An Evening of Icons

The industry celebrated its most precious asset—its people—at The Pierre in New York City on February 3 with a dinner honoring the two most recent inductees to the Medical Advertising Hall of Fame and the 2015 "Future Famers"

Features How to Win an MM&M Award: 2015

How to Win an MM&M Award: 2015

You have fewer than six weeks to enter the MM&M Awards. No problem. Follow our checklist of Do's and Don'ts and tune in to our webcast on March 24 for more tips.

Features

Partner Forum: Can evidence show POC the way?

EHRs can deliver evidence-based information about giving the right medicine to the right patient at the right time. How can industry craft point-of-care marketing that is both relevant and useful?

Features Marketing Research: Collaboration Proclamation

Marketing Research: Collaboration Proclamation

The combination of EHR, sensor and biomarker data is working to break down traditional barriers to collaboration among top-flight HEOR researchers

Features Multichannel Marketing: Multichannel Matures

Multichannel Marketing: Multichannel Matures

Most healthcare marketers understand the need for their programs to live in a range of channels. Now comes the hard part: Balancing their efforts across the multichannel spectrum. Michael Spitz offers some advice to marketers who get the "why" but need some help with the "how"

Features Mobile Marketing: It's Go Time

Mobile Marketing: It's Go Time

The sales reps are game, the HCPs are receptive and the mobile technology is ready. Rebecca Mayer Knutsen reports on the circumstances that have converged to provide pharma with its most promising mobile selling moment to date

Features Therapeutic Focus: Metabolic

Therapeutic Focus: Metabolic

Is this finally the year that anti-obesity drugs make the leap from niche curio to mainstream therapy? Frank Celia reports on the changing practitioner mind-set that could shift odds in favor of several new weight-loss options

Features Formulary Fireworks

Formulary Fireworks

In the wake of the high-profile showdown between Gilead and Express Scripts over the pricing of hepatitis-C drugs Sovaldi and Harvoni, the pharma/PBM balance of power may well have shifted—but not to the degree that many observers had predicted

Features Journal Ad Review: Back in the Mix

Journal Ad Review: Back in the Mix

A few years ago medical publishers were approaching a cliff and the choices were simple: Evolve the business or fall over the edge. By having learned to survive, some publishers are now ready to thrive

Features Dan Renick, Co-President and CCO, Precision for Medicine

Dan Renick, Co-President and CCO, Precision for Medicine

Session: Precision Medicine

Features Headliner: New Synta chief adds commercialization clout

Headliner: New Synta chief adds commercialization clout

Anne Whitaker, President and CEO, Synta Pharmaceuticals

Features Peter Frishauf, Director, Context Matters Inc.

Peter Frishauf, Director, Context Matters Inc.

Session: Battle of the Big Idea

Features Nirav "Rav" Sheth, Director of Market Development, Medical, MC10

Nirav "Rav" Sheth, Director of Market Development, Medical, MC10

Session: The wearable experience

Features Read the complete February 2015 Digital Edition

Read the complete February 2015 Digital Edition

Click the above link to access the Digital Edition of the February 2015 issue of MM&M, with all text, charts and pictures.

Features MM&M Awards—Fields of Gold

MM&M Awards—Fields of Gold

The MM&M Awards 2015 program is officially open for business

Features

Does account + creative ≠ agency?

Changing pharma demands and the ever-expanding skills of job seekers (tech, UX, search, mobile) have altered agency team structure. How must agency-client relations change to keep to the new model?

Features Nothing (Im)personal

Nothing (Im)personal

With unprecedented numbers of practices locking out sales reps, pharma companies are being forced to do a better job of engaging HCPs in other ways

Features Men of Agency

Men of Agency

Francis Gace and Dr. H. James Barnum took different paths to the top but each left a lasting mark on the advertising business. Barbara Peck celebrates the legacies of the two latest inductees to the Medical Advertising Hall of Fame

Features Hot Space

Hot Space

Our second annual survey of patients, physicians and payers reveals a significant degree of frustration—on every side—in an around the ever-booming specialty drug segment. Sarah Morgan interprets the results

Features David Weingard, Founder & CEO, Fit4D

David Weingard, Founder & CEO, Fit4D

Session: Intelligent Connections

Features Therapeutic Focus: Rare Diseases

Therapeutic Focus: Rare Diseases

The rare disease drug market is making history with its steady growth and burgeoning pipeline—and owing to continuing breakthroughs in gene therapy, the biggest advances are yet to come. Rebecca Mayer Knutsen reports on a sector that is thriving—and on the possibility that issues around pricing can slow its surge.

Features Mobile Marketing Report: On Hold

Mobile Marketing Report: On Hold

It's not as though pharma marketers didn't see mobile coming. For the past half decade, they've discussed its potential to transform behaviors and relationships within the healthcare ecosystem. Yet now that mobile has arrived, they find themselves torn between caution and exuberance. Larry Dobrow explains

Features Meg Columbia-Walsh, Partner, Global Lead of Digital Innovation and Marketing Excellence, Ernst & Young

Meg Columbia-Walsh, Partner, Global Lead of Digital Innovation and Marketing Excellence, Ernst & Young

Session: Inter-generational Executive Summit Panel

Features Josh Stein, CEO & Co-Founder, AdhereTech

Josh Stein, CEO & Co-Founder, AdhereTech

Session: Inter-generational Executive Summit Panel

Features Benjamin Wolin, CEO & Co-Founder, Everyday Health

Benjamin Wolin, CEO & Co-Founder, Everyday Health

Session: Inter-generational Executive Summit Panel

Features Ingo Elfering, Chief Information Officer, Indivior

Ingo Elfering, Chief Information Officer, Indivior

Session: Navigating Pharma Internal

Features Michele Polz, Head, Patient Insights, Global Commercial Strategy, Biogen

Michele Polz, Head, Patient Insights, Global Commercial Strategy, Biogen

Session: Rapid innovation and Big Pharma

Features Headliner: Scientist CEO sets sights on Sierra Leone

Headliner: Scientist CEO sets sights on Sierra Leone

Thomas Sack, President and CEO, MRIGlobal

Features The Top 40 Healthcare Transformers

The Top 40 Healthcare Transformers

Change within a set-in-its-ways industry can be scary—that is, unless you've got the will and bravado to tackle it head-on. Here are the 40 inventors, ­strategists, advocates and wonks who are challenging, disrupting and otherwise transforming the healthcare business.

Features

Read the complete January 2015 Digital Edition

Click the above link to access the complete Digital Edition of the January 2015 issue of MM&M, with all text, charts and pictures.

Features Phone-free connections?

Phone-free connections?

At any well-run business meeting, a smartphone is not only disruptive but also signals that its user is less than fully engaged with the business at hand

Features How to get clients to rethink the status quo

How to get clients to rethink the status quo

We need to help our health systems and healthcare companies function like agile start-ups

Features

Is pharma equipped to prove value?

Delivering better patient outcomes takes the right economic instruments. Do market-access teams have the right tools at their disposal to make the value-for-money argument?

Features Communication Shakedown

Communication Shakedown

Long the only game in town, health insurers—many have observed—never mastered the art of customer service. But with a host of tech- and service-savvy upstarts making plays for "their" customers, the rules have changed. Sarah Mahoney examines how the new breed of insurers—who mix high tech with high touch—are trying to outflank the establishment

Features "I" in the Sky

"I" in the Sky

In theory, healthcare marketers love the idea of beacons. In practice? Well, nobody's sure whether patients and physicians will be wowed by their utility or turned off by their invasiveness. Barbara Peck offers a Beacons 101 primer

Features

Partner Forum: Is data the key to trial recruitment?

LabCorp's purchase of CRO Covance promises to open access to LabCorp's patient database for trial recruiting. Can this help resolve problems like the disparity of female representation and scarcity of subjects for studies?

Features CROs: Trial Blazing

CROs: Trial Blazing

Running clinical trials remains one of Big Pharma's biggest headaches. But thanks to canny use of social media, gamification techniques and even text messages, CROs have revitalized and revolutionized the process. Barbara Peck explains

Features Data Management: Brace for the Breach

Data Management: Brace for the Breach

The specter of a massive hack is haunting the healthcare industry. As it turns out, that might not necessarily be a bad thing for everyone involved. Sarah Mahoney explains

Features The Pipeline Report 2015: Dream Drugs

The Pipeline Report 2015: Dream Drugs

These 16 sprouts, from a field of 156, are looking up. With more nurturing, their buds could blossom. Marc Iskowitz reports

Features Outlook 2015: Street Science

Outlook 2015: Street Science

Buoyed by unprecedented success in hepatitis C, the biotech and pharma sectors had a strong 2014. And to hear ace Evercore ISI analyst Dr. Mark Schoenebaum tell it, everything's in place for growth in 2015 and beyond. Here, he takes both a look back and a look forward

Features Outlook 2015: The Tax Man Cometh

Outlook 2015: The Tax Man Cometh

For years, Congress has batted around the possibility of tax reform—and with it, the reduction or elimination of the tax deduction for marketing expenses. Could 2015 be the year that reform comes to pass? Larry Dobrow attempts to answer this and other pressing policy questions

Features Programmatic buying stands to disrupt healthcare marketing

Programmatic buying stands to disrupt healthcare marketing

Programmatic ad buying hasn't exactly taken over the industry, but its approach has precipitated a paradigm shift, media experts say.

Features Read the complete December 2014 Digital Edition

Read the complete December 2014 Digital Edition

Click the above link to access the complete Digital Edition of the December 2014 issue of MM&M, with all text, charts and pictures.

Features Headliner: Pharma vet charts consultancy course

Headliner: Pharma vet charts consultancy course

Dennis Urbaniak, managing director, Accenture Life Sciences

Features Read the complete November 2014 Digital Edition

Read the complete November 2014 Digital Edition

Click the above link to access the complete Digital Edition of the November 2014 issue of MM&M, with all text, charts and pictures.

Features

Is guidance stifling social media?

Recent FDA draft guidance was meant to help companies create FDA-compliant tweets and handle third-party misinformation on the web. What other obstacles lie in the path of effective social media use?

Features

Point of Care and Engaging HCPs (November 2014)

A monthly showcase of companies offering expertise, experience and services within specific areas of the industry.

Features Leadership Exchange: Engaging the Digital Natives

Leadership Exchange: Engaging the Digital Natives

Striking the right tone in health communications with digital-savvy Millennials is tricky. Marc Iskowitz asks seven experts for some of the keys to facilitating that conversation

Features Therapeutic Focus 2014: Neurology

Therapeutic Focus 2014: Neurology

New therapies are shaking up MS and insomnia, while the slow pace of progress in Alzheimer's continues to frustrate patients and physicians alike. Welcome to neurology, where, Joe Dysart reports, treatment breakthroughs in certain areas are counteracted by setbacks in others

Features Cloud Marketing: Cloud Power

Cloud Marketing: Cloud Power

For all the talk about "the cloud," it promises most players in the pharma loop—sales and marketing execs, R&D teams and even the FDA—a better and faster way of doing business. Sarah Mahoney reports on how "the cloud" has become much more than a buzzword, and on what's inhibiting adoption

Features Point of Care: Ready to Wear

Point of Care: Ready to Wear

For the last few years, technology companies have been far more bullish about the potential of wearable health devices than healthcare organizations, never mind the consumers who were supposedly so eager to embrace them. New research, however, reveals that wearables may finally be catching on. Parks Associates' Harry Wang explains

Features Informed Targeting: Target Practice

Informed Targeting: Target Practice

As traditional saturation detailing and speaker programs lose ground, the advent of big data and analytics is letting pharma companies reach prized prescribers through new techniques like informed targeting and dynamic marketing. ZS Associates' Pratap Khedkar and Malcolm Sturgis explain

Features Engaging HCPs: Inhospitable

Engaging HCPs: Inhospitable

Hospitals used to be much more welcoming to pharma sales reps than they are today. Larry Dobrow looks at how the rise of the hospitalist has changed the game plan for getting the word out about products

Features Read the complete October 2014 Digital Edition

Read the complete October 2014 Digital Edition

Click the above link to access the complete Digital Edition of the October 2014 issue of MM&M, with all text, charts and pictures.

Features

Has risk information run rampant?

In an era when many patients prefer a conversation over a commercial, and as the FDA considers revisions to the "brief summary," how much risk information is necessary in DTC ads and why?

Features A court battle to crack "use codes"

A court battle to crack "use codes"

Hospira is taking to the courts to fight off generic threats to its hospital sedation drug Precedex

Features Therapeutic Focus 2014: Vaccines

Therapeutic Focus 2014: Vaccines

The anti-vaccination movement continues to make noise, but the Ebola scare has highlighted the role vaccines play in controlling diseases—and saving lives. Joe Dysart looks at the implications of the quest for an anti-Ebola vaccine, as well as the corporate shakeup in the vaccine sector.

Features Career Paths: The Climb

Career Paths: The Climb

As these eight pharma execs tell Larry Dobrow, achieving long-term success takes learning, listening, adapting and connecting with colleagues

Features Career & Salary Survey: In Check

Career & Salary Survey: In Check

Salaries are down,the industry gender gap persists and people have their eyes peeled for better gigs. But job satisfaction remains positive and, compared with other businesses, the pay isn't half-bad. James Chase attempts to make sense of the seeming contradictions

Features Headliner: HealthSpot's teleconnected CEO

Headliner: HealthSpot's teleconnected CEO

Steve Cashman, Founder and CEO, HealthSpot

Features FDA Social Media Guides Draw Industry, User Criticism

FDA Social Media Guides Draw Industry, User Criticism

Two FDA guidance documents on how health product manufacturers may participate in social media have each drawn criticism from affected industry and consumer groups.

Features Recruitment: The New Breed

Recruitment: The New Breed

What do healthcare agencies really want when it comes to potential employees? The answer to that question is in a constant state of flux, as technologies, clients' changing demands and the ever-expanding skill sets of a new generation of job seekers are transforming the rules of recruitment and hiring. Larry Dobrow reports

Features Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the September 2014 issue of MM&M, with all text, charts and pictures.

Features

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?

Features Therapeutic Focus 2014: Women's Health

Therapeutic Focus 2014: Women's Health

To see what's new in the women's health market, it might be necessary to take a look back. The return of the IUD is just one comeback shaping the future of a field that has never been a stranger to controversy. Noah Pines reports on the latest developments in this space

Features Patient Education/ Marketing: Keeping Pace with Patients

Patient Education/ Marketing: Keeping Pace with Patients

Welcome to patient education circa 2014: With patient expectations at an all-time high, pharma marketers are struggling to keep up in the quest to make meaningful contact with tech-empowered audiences. But a few savvy companies seem to have cracked the communication code, moving to the forefront of this movement. Larry Dobrow reports

Features Journal Ad Review: Reality Bites

Journal Ad Review: Reality Bites

Print's numbers may be taking some small steps in the right direction, but data is what the industry really wants to sink its teeth into. Larry Dobrow reports on what 2014's slight uptick means in the context of an evolving media mix

Features Headliner: Proteus CEO takes an original path

Headliner: Proteus CEO takes an original path

Andrew Thompson, CEO, Proteus Digital Health

 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.

Email Newsletters